ARS Pharmaceuticals, Inc. (SPRY) Total liabilities

annual total liabilities:

$94.36M+$91.93M(+3786.12%)
December 31, 2024

Summary

  • As of today (September 16, 2025), SPRY annual total liabilities is $94.36 million, with the most recent change of +$91.93 million (+3786.12%) on December 31, 2024.
  • During the last 3 years, SPRY annual total liabilities has risen by +$77.68 million (+465.81%).
  • SPRY annual total liabilities is now at all-time high.

Performance

SPRY Total liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSPRYbalance sheet metrics

quarterly total liabilities:

$121.15M+$22.81M(+23.19%)
June 30, 2025

Summary

  • As of today (September 16, 2025), SPRY quarterly total liabilities is $121.15 million, with the most recent change of +$22.81 million (+23.19%) on June 30, 2025.
  • Over the past year, SPRY quarterly total liabilities has increased by +$114.43 million (+1701.50%).
  • SPRY quarterly total liabilities is now at all-time high.

Performance

SPRY quarterly total liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSPRYbalance sheet metrics

Total liabilities Formula

Total Liabilities = Current Liabilities + Long-Term Liabilities

SPRY Total liabilities Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+3786.1%+1701.5%
3 y3 years+465.8%+696.6%
5 y5 years+344.0%-

SPRY Total liabilities Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+3786.1%at high+4889.7%
5 y5-yearat high+3786.1%at high+4889.7%
alltimeall timeat high+3786.1%at high+4889.7%

SPRY Total liabilities History

DateAnnualQuarterly
Jun 2025
-
$121.15M(+23.2%)
Mar 2025
-
$98.34M(+4.2%)
Dec 2024
$94.36M(+3786.1%)
$94.36M(+467.6%)
Sep 2024
-
$16.62M(+147.2%)
Jun 2024
-
$6.72M(+81.0%)
Mar 2024
-
$3.71M(+53.0%)
Dec 2023
$2.43M(-71.6%)
$2.43M(-78.5%)
Sep 2023
-
$11.27M(+10.5%)
Jun 2023
-
$10.20M(+1.6%)
Mar 2023
-
$10.04M(+151.6%)
Dec 2022
$8.55M
-
DateAnnualQuarterly
Sep 2022
-
$3.99M(-73.8%)
Jun 2022
-
$15.21M(-21.0%)
Mar 2022
-
$19.24M(-2.1%)
Dec 2021
$16.68M(+39.8%)
-
Dec 2021
-
$19.65M(-3.8%)
Sep 2021
-
$20.43M(+17.9%)
Jun 2021
-
$17.33M(+26.9%)
Mar 2021
-
$13.65M(+14.4%)
Dec 2020
$11.93M(-43.9%)
$11.93M(-43.9%)
Dec 2019
$21.25M(+127.3%)
$21.25M
Dec 2018
$9.35M
-

FAQ

  • What is ARS Pharmaceuticals, Inc. annual total liabilities?
  • What is the all time high annual total liabilities for ARS Pharmaceuticals, Inc.?
  • What is ARS Pharmaceuticals, Inc. annual total liabilities year-on-year change?
  • What is ARS Pharmaceuticals, Inc. quarterly total liabilities?
  • What is the all time high quarterly total liabilities for ARS Pharmaceuticals, Inc.?
  • What is ARS Pharmaceuticals, Inc. quarterly total liabilities year-on-year change?

What is ARS Pharmaceuticals, Inc. annual total liabilities?

The current annual total liabilities of SPRY is $94.36M

What is the all time high annual total liabilities for ARS Pharmaceuticals, Inc.?

ARS Pharmaceuticals, Inc. all-time high annual total liabilities is $94.36M

What is ARS Pharmaceuticals, Inc. annual total liabilities year-on-year change?

Over the past year, SPRY annual total liabilities has changed by +$91.93M (+3786.12%)

What is ARS Pharmaceuticals, Inc. quarterly total liabilities?

The current quarterly total liabilities of SPRY is $121.15M

What is the all time high quarterly total liabilities for ARS Pharmaceuticals, Inc.?

ARS Pharmaceuticals, Inc. all-time high quarterly total liabilities is $121.15M

What is ARS Pharmaceuticals, Inc. quarterly total liabilities year-on-year change?

Over the past year, SPRY quarterly total liabilities has changed by +$114.43M (+1701.50%)
On this page